Symposium commandité par Theratechnologies au EACS 2019 intitulé: “Beating resistance: finding new treatment paths for difficult-to-treat HIV patients”
November 7, 2019 - … intitulé: “Beating resistance: finding new treatment paths for difficult-to-treat HIV patients” Symposium commandité par … intitulé: “Beating resistance: finding new treatment paths for difficult-to-treat HIV patients” Nov 07, 2019 Company … intitulé: “Beating resistance: finding new treatment paths for difficult-to-treat HIV patients” …
Theratechnologies Issues Preliminary Revenue Estimates for Fiscal Year 2019 and Revenue Guidance for Fiscal Year 2020
December 19, 2019 - … Theratechnologies Issues Preliminary Revenue Estimates for Fiscal Year 2019 and Revenue Guidance for Fiscal Year 2020 Theratechnologies Issues Preliminary … is available on the Company’s website at www.theratech.com , on SEDAR at www.sedar.com and on EDGAR at …
Theratechnologies’ CFO to Attend Piper Jaffray 31st Annual Healthcare Conference in New York City
November 27, 2019 - … medical needs by bringing to market specialized therapies for people with orphan medical conditions, including those … is available on the Company’s website at www.theratech.com , on SEDAR at www.sedar.com and on EDGAR at … of our annual information form dated February 20, 2019 for additional risks regarding the conduct of our business …
Theratechnologies Starts Commercialization of New EGRIFTA SV™ in the United States
November 25, 2019 - … will have access to a new formulation of tesamorelin for the reduction of hard belly (excess hard abdominal fat) … of tesamorelin, EGRIFTA SV TM should help sustain growth for tesamorelin over the coming years. We are committed to … myalgia and peripheral edema. Refer to www.egriftasv.com for the full prescribing information, patient …
Theratechnologies’ CFO to Attend Stifel Healthcare Conference in New York City
November 14, 2019 - … medical needs by bringing to market specialized therapies for people with orphan medical conditions, including those … is available on the Company’s website at www.theratech.com , on SEDAR at www.sedar.com and on EDGAR at … of our annual information form dated February 20, 2019 for additional risks regarding the conduct of our business …
Trogarzo® Remains Effective Close to a Decade After Treatment Initiation
November 7, 2019 - … safe and effective in patients having been on treatment for almost a decade. Results come from a sub-analysis of … Phase 3 clinical trial TMB-301. At time of last TMB-311 visit, all 12 patients rolled over from the Phase 2 clinical … Full prescribing information available at www.trogarzo.com About Theratechnologies Theratechnologies (TSX: TH) …
Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing
October 10, 2019 - … biopharmaceutical company addressing unmet medical needs for people with orphan medical conditions, including those … NASDAQ listing is yet another step forward for our Company with growing sales from two commercialized … We are also aggressively developing our promising pipeline for the treatment of NASH in HIV (non-alcoholic …
Theratechnologies Announces Financial Results for the Third Quarter of 2019
October 8, 2019 - … Theratechnologies Announces Financial Results for the Third Quarter of 2019 Theratechnologies Announces Financial Results for the Third Quarter of 2019 Oct 08, 2019 Press Releases … (TSX: TH) today announced its financial results for the third quarter ended August 31, 2019. Third quarter …
European Commission Approves Trogarzo®
September 26, 2019 - … the European Commission represents a historical milestone for Theratechnologies as it becomes our first product ever … approved in that territory. We have been getting ready for this moment and we will initiate our launch plan to … which shows that there is already a high level of interest for our unique HIV treatment,” said Luc Tanguay, President …
La FDA autorise le protocole d’étude d’un nouveau mode d’administration de Trogarzo(MD)
March 4, 2019 - … sur le site Web de la Société au www.theratech.com et sur SEDAR au www.sedar.com . Information … Supporting Materials: FDA Authorizes Study Protocol for New Mode of Administration for Trogarzo® 232.8 KB MONTRÉAL, 04 mars 2019 (GLOBE … Supporting Materials: FDA Authorizes Study Protocol for New Mode of Administration for Trogarzo® 232.8 KB …